Neogen (NEOG) Common Equity (2011 - 2026)

Neogen has reported Common Equity for 16 years, with the latest figure at $2.1 billion in Q2 2026.

• On a quarterly basis, Common Equity rose 1.05% year-over-year to $2.1 billion in Q2 2026; TTM through May 2026 was $2.1 billion, a 1.05% increase from a year earlier, with the FY2026 full-year figure at $2.1 billion, up 1.05% from the prior year.
• Common Equity was $2.1 billion for Q2 2026 at Neogen, roughly flat from $2.1 billion in the prior quarter.
• The five-year high for Common Equity was $3.1 billion in Q4 2023, with the low at $875.5 million in Q1 2022.
• Average Common Equity over 5 years is $2.4 billion, with a median of $2.7 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Common Equity soared 258.91% in 2022, then plunged 34.13% in 2025.
• Over 5 years, Common Equity stood at $3.1 billion in 2022, then climbed by 1.33% to $3.1 billion in 2023, then dropped by 15.2% to $2.7 billion in 2024, then retreated by 21.15% to $2.1 billion in 2025, then fell by 0.55% to $2.1 billion in 2026.
• The last three Common Equity figures came in at $2.1 billion (Q2 2026), $2.1 billion (Q1 2026), and $2.1 billion (Q4 2025), per Business Quant data.